article · Multiple Sclerosis and Related Disorders

159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes

Jiwon Oh
Mariken E. Luca
Mounir Khoury
Laura Negrotto
Meritxell Sabidó-Espin
Joseph El Youssef
Mariana Deramo
Murad Al-Naqshbandi
Tom Quinn
Kate Morgan
Sabrina de Souza
Raed Alroughani
Mavis Ayer
Michela Bossolasco
Samar Farouk Ahmed
Amir Boshra
Berenice Silva

2024Minia University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Acute Lymphoblastic Leukemia research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.msard.2024.106120

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.